Lexpos News

/Lexpos News/

NHS prescription charges frozen for the second year running

The Department of Health and Social Care (DHSC) has announced that the NHS prescription charge will remain at £9.90 per prescription item for 2026/27. A Government press release today confirms that the NHS prescription charge will be frozen, as well as the costs for prescription prepayment certificates (PPCs). The list of 2026/27 prescription-related charges are outlined below. [...]

The post NHS prescription charges frozen for the second year running appeared first on Community Pharmacy England.

By |November 21st, 2025|Lexpos News|Comments Off on NHS prescription charges frozen for the second year running

Integration, localism and prevention key to building a future-fit NHS

Politicians and policy experts have cited integration, localism and prevention as some of the core components required to build a future-fit NHS. The themes have been identified in a written report on Community Pharmacy England’s series of policy events at this year’s political party conferences. The discussions concluded that community pharmacy, in particular, is foundational [...]

The post Integration, localism and prevention key to building a future-fit NHS appeared first on Community Pharmacy England.

By |November 21st, 2025|Lexpos News|Comments Off on Integration, localism and prevention key to building a future-fit NHS

Underinvestment threatening patient access to pharmacy, Health APPG hears

Underinvestment in the sector is continuing to threaten the accessibility of community pharmacies to patients and the public, Community Pharmacy England has told a Parliamentary inquiry. Dr. James Davies, Director of Research and Insights at Community Pharmacy England, gave oral evidence to the All-Party Parliamentary Health Group (APHG) on Wednesday 19th November. The APHG’s inquiry [...]

The post Underinvestment threatening patient access to pharmacy, Health APPG hears appeared first on Community Pharmacy England.

By |November 20th, 2025|Lexpos News|Comments Off on Underinvestment threatening patient access to pharmacy, Health APPG hears

National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy

National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy National Patient Safety Alert Reference Number: NatPSA/2025/006/NHSPS Date issued: 20 November 2025 Explanation of identified safety issue There are reports of healthcare staff recording a patient’s penicillin allergy as a penicillamine allergy in electronic prescribing systems. This look-alike sound-alike [...]

The post National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy appeared first on Community Pharmacy England.

By |November 20th, 2025|Lexpos News|Comments Off on National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy

MHRA Class 3 Medicines Recall: Fingolimod SUN 0.5mg hard capsules (Sun Pharmaceutical Industries Limited)

MHRA Class 3 Medicines Recall: Fingolimod SUN 0.5mg hard capsules (Sun Pharmaceutical Industries Limited) Drug Alert Number: EL(25)A/49 Date issued: 20 November 2025 Sun Pharma UK Limited is conducting a precautionary recall of a single batch of Fingolimod SUN 0.5 mg hard capsules due to reports of capsule breakage on removing from the blister. No other [...]

The post MHRA Class 3 Medicines Recall: Fingolimod SUN 0.5mg hard capsules (Sun Pharmaceutical Industries Limited) appeared first on Community Pharmacy England.

By |November 20th, 2025|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Fingolimod SUN 0.5mg hard capsules (Sun Pharmaceutical Industries Limited)